London, UK – 5 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has signed a Memorandum of Understanding (MoU) with South London and Maudsley NHS Foundation Trust (SLaM) and the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at King’s College London…


Previous articlePsychedelic Bulletin: Harvard Law School Launches Psychedelics Project; California Decrim. Bill Clears Latest Hurdle; LSD for Food Allergies?
Next articleCybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence